AZD5438, a potent oral inhibitor of cyclin-dependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenografts.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples